Chiral C1-symmetric 2,2′:6′,2′′-terpyridine ligands: Synthesis,characterization, complexation with copper(II), rhodium(III) and ruthenium(II) ions and use of the complexes in catalytic cyclopropanation of styrene

Three new optically pure C₁-terpyridine ligands (L1–3) were prepared and the copper(II) complexes, of formula [Cu(L)Cl₂], the rhodium(III) complexes, of formula [Rh(L)Cl₃], and the ruthenium(II) complexes, of formula cis- or trans-[Ru(L)(X)Cl₂] (X = DMSO or CO), were synthesized. Structures of a chiral C₁-ligand, a copper complex, a rhodium complex and a ruthenium DMSO complex were analysed using X-ray crystal structure analysis. The copper, rhodium and ruthenium complexes were shown to be precursors of catalysts for cyclopropanation. Reaction of [Cu(L)Cl₂], [Rh(L)Cl₃] or cis- or trans-[Ru(L)(X)Cl₂] with AgOTf converted the complex to catalyst, which in the case of trans-[Ru(L)(CO)Cl₂] gave enantioselectivities of up to 67% ee for the cis-isomers of styrene cyclopropanes with t-butyl diazoacetate. Comparisons with C₂-analog of copper, rhodium and ruthenium catalysts were made.     

New chiral bidentate ligands containing thiazolyl and pyridyl donors for copper-catalyzed asymmetric allylic oxidation of cyclohexene

Chiral bidentate ligands 1-3, which contain a combination of thiazolyl and pyridyl donors units, were prepared. The syntheses are facile and being based on Kröhnke condensation of a pinene derivative to form the pyridine ring. Modification at the 8-position of the tetrahydroquinoline ring can be carried out by alkylation reaction with 2a and 3a but not 1a. The structure of a copper(II) perchlorate complex of 1a was characterized with X-ray crystallography, which reveals the binding of the pyridyl-thiazole as a N-N donors at the copper center. The copper(I) thiazolyl-pyridine complexes prepared in situ are active catalysts in the enantioselective allylic oxidation of cyclohexene using tert-butyl perbenzoate as the oxidant. The isolated yields of the allylic benzoate were up to 98%, and enantioselectivity was up to 62% e.e.     

Nickel-catalyzed asymmetric alpha-arylation of ketone enolates

An atropisomeric dipyridyldiphosphine, P-Phos, can effect highly enantioselective Ni-catalyzed alpha-arylation of ketone enolates with aryl halides to install an all-carbon quaternary stereogenic center in up to 98% ee and excellent yields.     

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target

Epstein Barr virus (EBV)-associated lymphoproliferative diseases (LPDs) express all EBV latent antigens (type III latency) in immunodeficient patients and limited antigens (type I and II latencies) in immunocompetent patients. Post-transplantation lymphoproliferative disease (PTLD) is the prototype exhibiting type III EBV latency. Although EBV antigens are highly immunogenic, PTLD cell proliferation remains unchecked because of the underlying immunosuppression. The restoration of anti-EBV immunity by EBV-specific T cells of either autologous or allogeneic origin has been shown to be safe and effective in PTLDs. Cellular therapy can be improved by establishing a bank of human leukocyte antigen-characterized allogeneic EBV-specific T cells. In EBV+ LPDs exhibiting type I and II latencies, the use of EBV-specific T cells is more limited, although the safety and efficacy of this therapy have also been demonstrated. The therapeutic role of EBV-specific T cells in EBV+ LPDs needs to be critically reappraised with the advent of monoclonal antibodies and other targeted therapy. Another strategy involves the use of epigenetic approaches to induce EBV to undergo lytic proliferation when expression of the viral thymidine kinase renders host tumor cells susceptible to the cytotoxic effects of ganciclovir. Finally, the prophylactic use of antiviral drugs to prevent EBV reactivation may decrease the occurrence of EBV+ LPDs.     

Inequalities for combinatorial sums

For \(k,l\in \mathbf {N}\), let

$$\begin{aligned}&P_{k,l}=\Bigl (\frac{l}{k+l}\Bigr )^{k+l} \sum _{\nu =0}^{k-1} {k+l\atopwithdelims ()\nu } \Bigl (\frac{k}{l}\Bigr )^{\nu }\\&\quad \text{ and }\quad Q_{k,l}=\Bigl (\frac{l}{k+l}\Bigr )^{k+l} \sum _{\nu =0}^{k} {k+l\atopwithdelims ()\nu } \Bigl (\frac{k}{l}\Bigr )^{\nu }. \end{aligned}$$

We prove that the inequality

$$\begin{aligned} \frac{1}{4}\le P_{k,l} \end{aligned}$$

is valid for all natural numbers k and l. The sign of equality holds if and only if \(k=l=1\). This complements a result of Vietoris, who showed that

$$\begin{aligned} P_{k,l}<\frac{1}{2} \quad {(k,l\in \mathbf {N})}. \end{aligned}$$

An immediate corollary is that

$$\begin{aligned} \frac{1}{4}\le P_{k,l}<\frac{1}{2} <Q_{k,l}\le \frac{3}{4} \quad {(k,l\in \mathbf {N})}. \end{aligned}$$

The constant bounds are sharp.

     

Palladium-catalyzed cross-coupling reactions of aryl mesylates

Palladium-catalyzed cross-coupling reactions are state-of-the art methods for synthesis of many important compounds. The development of the use of the phenol-derived sulfonated hydroxyl group in the coupling reactions is highly attractive as the hydroxyl group is commonly present in organic compounds and they are versatile alternatives to aryl halides in cross-coupling reactions. In this tutorial review, we summarize the current development of palladium-catalyzed cross-coupling reactions of aryl mesylates.     

A Small‐Molecule AIE Chromosome Periphery Probe for Cytogenetic Studies

The chromosome periphery (CP) is a complex network that covers the outer surface of chromosomes. It acts as a carrier of nucleolar components, helps maintain chromosome structure, and plays an important role in mitosis. Current methods for fluorescence imaging of CP largely rely on immunostaining. We herein report a small‐molecule fluorescent probe, ID‐IQ , which possesses aggregation‐induced emission (AIE) property, for CP imaging. By labelling the CP, ID‐IQ sharply highlighted the chromosome boundaries, which enabled rapid segmentation of touching and overlapping chromosomes, direct identification of the centromere, and clear visualization of chromosome morphology. ID‐IQ staining was also compatible with fluorescence in situ hybridization and could assist the precise location of the gene in designated chromosome. Altogether, this study provides a versatile cytogenetic tool for improved chromosome analysis, which greatly benefits the clinical diagnostic testing and genomic research.     

DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins

Whether for pathological examination or for fundamental biology studies, different classes of biomaterials and biomolecules are each measured from a different region of a typically heterogeneous tissue sample, thus introducing unavoidable sources of noise that are hard to quantitate. We describe the method of DNA-encoded antibody libraries (DEAL) for spatially multiplexed detection of ssDNAs and proteins as well as for cell sorting, all on the same diagnostic platform. DEAL is based upon the coupling of ssDNA oligomers onto antibodies which are then combined with the biological sample of interest. Spotted DNA arrays, which are found to inhibit biofouling, are utilized to spatially stratify the biomolecules or cells of interest. We demonstrate the DEAL technique for (1) the rapid detection of multiple proteins within a single microfluidic channel, and, with the additional step of electroless amplification of gold-nanoparticle labeled secondary antibodies, we establish a detection limit of 10 fM for the protein IL-2, 150 times more sensitive than the analogue ELISA; (2) the multiplexed, on-chip sorting of both immortalized cell lines and primary immune cells with an efficiency that exceeds surface-confined panning approaches; and (3) the co-detection of ssDNAs, proteins, and cell populations on the same platform.